Your session is about to expire
← Back to Search
Product B: Non-Combusted Cigarette Variant 42001399 and product use Mode B for Smoking
Study Summary
This trial will test whether switching to the study's investigational products (IPs) is safer for generally healthy smokers than continuing to smoke, undergoing smoking abstinence, or never having smoked.
- Smoking
- Tobacco Use
- Tobacco Smoking
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this trial have vacancies for participants?
"According to clinicaltrials.gov, this trial is not at present recruiting patients. Initially posted on January 13th 2022 and last updated December 2nd 2022, no participants are being sought for the study. Nonetheless 138 other medical trials are now taking applicants."
Who is qualified to partipate in this clinical research experiment?
"To participate in this trial, individuals must meet two criteria: they need to be between the ages of 26 and 55 and have a history of tobacco use. The research team aims to recruit 806 people."
Are there any geographic limitations to this research initiative?
"Monroe Biomedical Research, Centricity Research and Clinical Trials of Texas are the three major sites for this trial. Additionally, 15 other clinical locations across America have been enlisted to recruit patients."
Does this trial accept individuals under eighty years of age?
"This clinical trial has established 26 years old as the minimum age for participation, with a maximum of 55."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger